• FAQ
Prophase Logo
open menu
  • About Us
    • About Us
    • Management Team
  • Our Companies
    • Nebula Genomics
    • ProPhase Diagnostics
    • ProPhase Biopharma
    • Pharmaloz Manufacturing
    • TK Supplements
  • Investor Relations
    • Presentations
    • News & Events
      • Press Releases
      • Media Mentions
      • IR Calendar
      • Email Alerts
    • Company Info
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact Us
    • Corporate
    • Diagnostics
    • Pharmaloz
    • TKSupplements

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • News & Events
    • Press Releases
    • Media Mentions
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Media Mentions
  • IR Calendar
  • Email Alerts
Aug 07, 2024 8:00am EDT

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

Jul 11, 2024 8:00am EDT

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

May 09, 2024 3:40pm EDT

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

May 09, 2024 8:00am EDT

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.

May 02, 2024 8:00am EDT

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9

Apr 25, 2024 8:00am EDT

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 16, 2024 8:00am EDT

ProPhase Labs Unveils Project ZenQ-AI

Apr 10, 2024 8:00am EDT

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

Apr 01, 2024 9:00pm EDT

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 15, 2024 8:00am EDT

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …23
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Prophase Logo

© Copyright - ProPhase Labs, Inc.
All Rights Reserved.

  • About Us
  • Our Companies
  • Investor Relations
  • Contact Us
  • Site Map
  • Legal Notice
  • Accessibility